Drug Profile
Telmisartan/hydrochlorothiazide - Boehringer Ingelheim
Alternative Names: BIBR 277HCT; Kinzalkomb; Micardis Plus; MicardisPlus 80/25; Micombi; Pritor PlusLatest Information Update: 08 Mar 2022
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Developer Astellas Pharma; Bayer; Boehringer Ingelheim Pharma KG
- Class Antihypertensives; Benzimidazoles; Benzoates; Benzothiadiazines; Small molecules
- Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists; Thiazide diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension